You just read:

Complete Efficacy and Long-Term Follow-Up Safety Results from SGX942 Phase 2 Oral Mucositis Clinical Trial to be Presented at the 2017 Multinational Association for Supportive Care in Cancer Conference

News provided by

Soligenix, Inc.

Jun 19, 2017, 06:00 ET